Expanded access use of Lucanix in five patients with advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2011
At a glance
- Drugs Belagenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Feb 2011 New trial record